Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.04 USD | -0.43% | +1.52% | -2.00% |
Apr. 29 | North American Morning Briefing : Investors Brace -2- | DJ |
Mar. 25 | Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.00% | 957M | |
-1.27% | 104B | |
+7.29% | 97.47B | |
+5.71% | 22.25B | |
-12.87% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.63% | 16.36B | |
+8.58% | 14.39B | |
+39.34% | 12.37B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Insider Buy: Cassava Sciences